NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
PPH is associated with almost 20 per cent of maternal mortality in India
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The product is expected to be launched in June 2023
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Subscribe To Our Newsletter & Stay Updated